KDR and cancer: The Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) and Cyclin-Dependent Kinase 4 (CDK4) are the most important therapeutic targets in cancer research because of their pivotal roles in cancer processes, angiogenesis, and uncontrolled proliferation, respectively.